NYSE:PBHPharmaceuticals
Assessing Prestige Consumer Healthcare (PBH) Valuation After Weaker Earnings And Narrowed Revenue Guidance
Prestige Consumer Healthcare (PBH) has drawn investor attention after its latest quarterly results showed lower sales and net income versus the prior year, along with a slightly narrowed full year revenue outlook.
See our latest analysis for Prestige Consumer Healthcare.
Those earnings and the slightly tighter revenue outlook come after a solid 90 day share price return of 13.24% and a 5 year total shareholder return of 61.60%, set against a weaker 1 year total shareholder return decline of...